Why Doctors Are Warning Against the Internet’s Newest “Miracle” Weight Loss Drug
Some clinical trial participants are dropping out not because the drug isn’t working, but because it’s working too well. They are losing weight so rapidly they’ve simply decided to stop.
This is the buzz surrounding retatrutide, the "triple-agonist" injectable currently being hailed as the next frontier in metabolic health.
While the world is still catching its breath from the Ozempic and Wegovy craze, a new, more potent chemical relative is waiting in the wings. But as the hype travels from medical journals to social media feeds in Accra and London alike, a dangerous "gray market" is emerging for a drug that technically doesn't exist yet for public use.
The Triple-Threat Mechanism
For those who have struggled with weight loss despite a disciplined diet or even existing GLP-1 m...
